Association of Gonadotropin-Releasing Hormone Therapies With Venous Thromboembolic Events in Patients With Prostate Cancer: A National Cohort Study.

Front Cardiovasc Med · 2022 · PMC8966087 · PMID 35369325

Europe PMC DOI

hedged sentence

0.0367

closest p · 0.7× alpha

0.0367

boldest claim

The sentences

borderline level of statistical significancep = 0.0367actually significant

The Risks of VTEs in Prostate Cancer Patients Receiving GnRH Therapies In the Cox regression analysis, the 5-year risk VTEs were higher among GnRH users than among non-users at a borderline level of statistical significance (adjusted HR: 1.51; CI: 1.03–2.22, p = 0.0367; Table 2 ).

also in 49 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.